Research and Markets: Complete 2012 Induced Pluripotent Stem Cell Industry Report

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/p9c5cg/complete_2012_indu) has announced the addition of the "Complete 2012 Induced Pluripotent Stem Cell Industry Report" report to their offering.

Diseases such as Huntington's Chorea, Parkinson's Disease, and spinal cord injuries are just some examples of potential clinical applications where stem cells can offer potential benefits in halting or even reversing medical conditions that previously had no positive outcome potential - and induced pluripotent stem cells represent a preferred cell type for this type of disease reversal research.

Traditionally, scientists have worked with both embryonic and adult stem cells. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding the use of embryonic cells for research. Although adult stem cells can differentiate slightly, they are typically limited to differentiation within their original tissue type, creating narrow options for their use.

What's In This Report:

- Charts, Timelines, Metrics and Financials for the iPSC Research Product Market

- Trends for iPSC Grants, Publications, Patents, and More

- 5-Year Market Projection Data for 2012-2017

- Competitive Environment Analysis, Including Market Share by Competitor

- Preferred Species for iPSC Research

Read this article:
Research and Markets: Complete 2012 Induced Pluripotent Stem Cell Industry Report